In a recent paper, the authors explored the involvement of NRP1 in doxorubicin sensitivity of breast cancer cells; they showed that the VEGF-A/NRP1 axis promoted cancer stem cells (CSCs) self-renewal via the Wnt/β-catenin pathway [35]. Here, NRP1 is linked to cancer.